References
- Thein SL. The molecular basis of β-thalassemia. Cold Spring Harb Perspect Med. 2013;3(5):a011700.
- Vinciguerra M, Cannata M, Cassarà F, et al. HBB: c.316-125A>G and HBB: c.316-42delC: phenotypic evaluations of two rare changes in the second intron of the HBB gene. Hemoglobin. 2017;41(4–6):234–238.
- Cao A, Kan YW. The prevention of thalassemia. Cold Spring Harb Perspect Med. 2013;3(2):a011775.
- Steinberg MH, Forget BG, Higgs DR, Weatherall DJ, editors. Disorders of hemoglobin genetics, pathophysiology, and clinical management. 2nd ed. New York (NY, USA): Cambridge University Press; 2009.
- Patrinos GP, Kollia P, Papadakis MN. Molecular diagnosis of inherited disorders: lessons from hemoglobinopathies. Hum Mutat. 2005;26(5):399–412.
- Williams TN, Weatherall DJ. World distribution, population genetics, and health burden of the hemoglobinopathies. Cold Spring Harb Perspect Med. 2012;2(9):a011692.
- Mahdieh N, Rabbani B. Beta thalassemia in 31,734 cases with HBB gene mutations: pathogenic and structural analysis of the common mutations; Iran as the crossroads of the Middle East. Blood Rev. 2016;30(6):493–508.
- Chong SS, Boehm CD, Higgs DR, et al. Single-tube multiplex-PCR screen for common deletional determinants of α-thalassemia. Blood. 2000;95(1):360–362.
- Bendl J, Musil M, Stourac J, et al. PredictSNP2: a unified platform for accurately evaluating SNP effects by exploiting the different characteristics of variants in distinct genomic regions. PLoS Comput Biol. 2016;12(5):e1004962.
- Rentzsch P, Witten D, Cooper GM, et al. CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res. 2019;47(D1):D886–D894.
- Quang D, Chen Y, Xie X. DANN: a deep learning approach for annotating the pathogenicity of genetic variants. Bioinformatics. 2015;31(5):761–763.
- Shihab HA, Gough J, Mort M, et al. Ranking non-synonymous single nucleotide polymorphisms based on disease concepts. Hum Genomics. 2014;8(8):11.
- Fu Y, Liu Z, Lou S, et al. FunSeq2: a framework for prioritizing noncoding regulatory variants in cancer. Genome Biol. 2014;15(10):480.
- Ritchie GR, Dunham I, Zeggini E, et al. Functional annotation of noncoding sequence variants. Nat Methods. 2014;11(3):294–296.
- Schwarz JM, Cooper DN, Schuelke M, et al. MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods. 2014;11(4):361–362.
- Basran RK, Reiss UM, Luo H, et al. β thalassemia intermedia due to compound heterozygosity for two β-globin gene promoter mutations, including a novel TATA box deletion. Pediatr Blood Cancer. 2008;50(2):363–366.
- Moi P, Faà V, Marini MG, et al. A novel silent β thalassemia mutation in the distal CACCC box affects the binding and responsiveness to EKLF. Br J Haematol. 2004;126(6):881–884.
- Stuve LL, Myers RM. A directly repeated sequence in the β-globin promoter regulates transcription in murine erythroleukemia cells. Mol Cell Biol. 1990;10(3):972–981.
- Li D-Z, Liao C, Xie X-M, et al. A novel mutation of -50 (G→A) in the direct repeat element of the β-globin gene identified in a patient with severe β-thalassemia. Ann Hematol. 2009;88(11):1149–1150.
- Agouti I, Bennani M, Nezri M, et al. β thalassemia intermedia due to two novel mutations in the promoter region of the β-globin gene. Eur J Haematol. 2008;80(4):346–350.
- Lewis BA, Kim T-K, Orkin SH. A downstream element in the human β-globin promoter: evidence of extended sequence-specific transcription factor IID contacts. Proc Natl Acad Sci USA. 2000;97(13):7172–7177.
- Van de Water N, Tan T, Chan G, et al. A +8 (C→T) mutation within the 5′ untranslated region of β-globin down-regulates the mRNA transcription. Hemoglobin. 2008;32(3):247–253.
- Athanassiadou A, Papachatzopoulou A, Zoumbos N, et al. A novel β-thalassaemia mutation in the 5′ untranslated region of the β-globin gene. Br J Haematol. 1994;88(2):307–310.
- Huang S-Z, Xu Y-H, Zeng F-Y, et al. A novel β-thalassaemia mutation: deletion of 4 bp (-AAAC) in the 5′ transcriptional sequence. Br J Haematol. 1991;78(1):125–126.